Search by Drug Name or NDC

    NDC 73292-0011-01 Viltepso 250 mg/1 Details

    Viltepso 250 mg/1

    Viltepso is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by NS Pharma, Inc.. The primary component is VILTOLARSEN.

    Product Information

    NDC 73292-0011
    Product ID 73292-011_660fd183-2dc3-4e7c-9695-6105573165c9
    Associated GPIs 74600080002020
    GCN Sequence Number 081384
    GCN Sequence Number Description viltolarsen VIAL 250 MG/5ML INTRAVEN
    HIC3 Z1R
    HIC3 Description GENETIC D/O TX-EXON SKIPPING ANTISENSE OLIGONUCLEO
    GCN 48472
    HICL Sequence Number 046773
    HICL Sequence Number Description VILTOLARSEN
    Brand/Generic Brand
    Proprietary Name Viltepso
    Proprietary Name Suffix n/a
    Non-Proprietary Name viltolarsen
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 250
    Active Ingredient Units mg/1
    Substance Name VILTOLARSEN
    Labeler Name NS Pharma, Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA212154
    Listing Certified Through 2024-12-31

    Package

    NDC 73292-0011-01 (73292001101)

    NDC Package Code 73292-011-01
    Billing NDC 73292001101
    Package 1 VIAL, GLASS in 1 CARTON (73292-011-01) / 1 INJECTION, SOLUTION in 1 VIAL, GLASS
    Marketing Start Date 2020-08-13
    NDC Exclude Flag N
    Pricing Information N/A